Development and validation of nomograms predicting survival in female patients with HER2-positive T1-3N0-1 breast cancer following breast-conserving surgery: a Surveillance, Epidemiology, and End Results database analysis
{{output}}
Background: Despite advances in human epidermal growth factor receptor 2 (HER2)-targeted therapies, HER2-positive early-stage breast cancer (BC) exhibits substantial outcome heterogeneity after breast-conserving surgery (BCS), co... ...
